Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
62,544,537
-
Share change
-
+809,628
-
Total reported value
-
$240,802,681
-
Put/Call ratio
-
86%
-
Price per share
-
$3.85
-
Number of holders
-
120
-
Value change
-
+$14,464,745
-
Number of buys
-
47
-
Number of sells
-
47
Institutional Holders of ZIOPHARM ONCOLOGY INC - COM (TCRT) as of Q1 2019
As of 31 Mar 2019,
ZIOPHARM ONCOLOGY INC - COM (TCRT) was held by
120 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
62,544,537 shares.
The largest 10 holders included
MSD Partners, L.P., VANGUARD GROUP INC, BlackRock Inc., MILLER VALUE PARTNERS, LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, DISCOVERY CAPITAL MANAGEMENT, LLC / CT, NORTHERN TRUST CORP, MORGAN STANLEY, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
120
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.